Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study

Background/Objectives: Diabetic macular edema (DME) is a significant cause of visual impairment, often treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, some patients do not respond adequately to this treatment. This study aims to evaluate the contribution of the intr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ferhat Turgut, Gábor M. Somfai, Christoph Tappeiner, Katja Hatz, Irmela Mantel, Aude Ambresin, Guy Donati, Viviane Guignard, Dana Nagyová, Isabel B. Pfister, Christine Schild, Justus G. Garweg
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-09-01
Col·lecció:	Pharmaceuticals
Matèries:	diabetic macular edema intravitreal dexamethasone implant anti-VEGF
Accés en línia:	https://www.mdpi.com/1424-8247/17/9/1235
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!